Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

global access

- PMLiVE

Freshen up your agency relationship

How to put the 'zing' back into how you and your agency work together

- PMLiVE

Alcon wins initial NICE backing for Jetrea in rare eye condition

Would be first alternative to surgery available to vitreomacular traction patients in England and Wales

Synexus South Africa research sites join Pfizer trial network

CRO's sites become the first in Africa to meet the pharma company's standards

- PMLiVE

Summit appoints Pfizer/Bayer veteran as CMO

David Roblin to lead development of therapies for Duchenne muscular dystrophy and C.difficile

- PMLiVE

Electronic medical records ‘could boost clinical trial efficiency’

Quicker recruitment times and lower development costs among potential benefits, says Parexel

- PMLiVE

PMEA 2013 opens for entry

Programme recognises responsible marketing and business practice in the healthcare industry

Fishawack Group acquires Archimed Medical Communication

Pharmacovigilance specialists adds to group’s Swiss footprint

- PMLiVE

BMS’ Orencia matches Humira in arthritis study

Data should help drug establish itself against AbbVie's market-leading RA medicine

- PMLiVE

France investigates Teva after packaging mix-up

Some packages of diuretic furosemide found to contain sleeping pill zopiclone

National Institute for Health and Care Excellence NICE logo

NICE U-turn on GSK’s Revolade

Watchdog says yes to blood disorder drug three years after initial knockback

- PMLiVE

New formulations of Pralia and Enbrel head list of new drugs in Japan

Regulator backs medicines from Pfizer, Takeda, Daiichi Sankyo, Astellas, Zeria and otsuka

- PMLiVE

Histogenics names former MedImmune president as CEO

Peter Greenleaf to lead regenerative medicine company

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links